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Abstract
Hydrophobic signal sequences target secretory polypeptides to a protein-conducting channel 
formed by a heterotrimeric membrane protein complex, the prokaryotic SecY or eukaryotic Sec61 
complex. How signal sequences are recognized is poorly understood, particularly because they are 
diverse in sequence and length. Structures of the inactive channel show that the largest subunit, 
SecY or Sec61α, consists of two halves that form an hourglass-shaped pore with a constriction in 
the middle of the membrane and a lateral gate that faces lipid1-10. The cytoplasmic funnel is 
empty, while the extracellular funnel is filled with a plug domain. In bacteria, the SecY channel 
associates with the translating ribosome in co-translational translocation, and with the SecA 
ATPase in post-translational translocation 11. How a translocating polypeptide inserts into the 
channel is uncertain, as cryo-EM structures of the active channel have a relatively low resolution 
(~10Å) or are of insufficient quality 6-8. Here we report a crystal structure of the active channel, 
assembled from SecY complex, the SecA ATPase, and a segment of a secretory protein fused into 
SecA. The translocating protein segment inserts into the channel as a loop, displacing the plug 
domain. The hydrophobic core of the signal sequence forms a helix that sits in a groove outside 
the lateral gate, while the following polypeptide segment intercalates into the gate. The C-terminal 
section of the polypeptide loop is located in the channel, surrounded by residues of the pore ring. 
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Thus, during translocation, the hydrophobic segments of signal sequences, and probably bilayer-
spanning domains of nascent membrane proteins, exit the lateral gate and dock at a specific site 
that faces the lipid phase.
To determine the structure of an active SecY channel, we initially generated in Escherichia 
coli a translocation intermediate, consisting of SecA, SecY complex, and a short segment of 
a secretory protein fused to a fast-folding green fluorescent protein (GFP) (Extended Data 
Fig.1a). Although this complex could be purified 12, it failed to crystallize. We therefore 
reduced the complexity of the system by fusing a short segment of a secretory protein 
directly into SecA. The segment contains the signal sequence of OmpA and a short 
polypeptide following it, and was inserted into the tip of the two-helix finger of SecA 
(SecA-OAIns; Fig. 1a; Extended Data Fig. 1b), because the finger was seen to protrude into 
the cytoplasmic cavity of SecY in a structure of SecA/SecY complex lacking a translocation 
substrate 9. Using E. coli SecA-OAIns and E. coli SecY complex, the inserted secretory 
protein segment was indeed translocated to the periplasm in E. coli, as demonstrated by the 
formation of a disulfide bridge between a cysteine introduced C-terminally of the signal 
sequence and a cysteine placed into the plug domain of SecY (Extended Data Fig.2a). This 
disulfide bridge formed spontaneously, i.e. without addition of an exogenous oxidant. The 
introduction of Gln residues into the hydrophobic core of the signal sequence abolished 
disulfide bridge formation (Extended Data Fig.2b), demonstrating that an intact signal 
sequence is required for translocation of the polypeptide segment. Similar results were 
obtained with Bacillus subtilis SecA-OAIns and Geobacillus thermodenitrificans SecYE 
(Extended Data Fig.2c), a complex of increased thermostability that is functional in E. coli. 
After optimization (Extended Data Fig. 2d-f), the construct chosen for crystallization 
contained 49 residues inserted into the two-helix finger of B. subtilis SecA, with a cysteine 
at position +7 in the region following the signal sequence of 20 residues. Channel insertion 
of the secretory protein segment was similar to that observed with the physiological system, 
containing wild type SecA and a GFP-fusion to a secretory protein fragment (Extended Data 
Fig.1), except that the latter requires an additional polypeptide segment to span the SecA 
molecule. Thus, our simplified system is a faithful mimic of normal initiation of protein 
translocation. Binding of SecA to the SecY complex seems to be sufficient to cause 
polypeptide chain insertion into the channel, similar to how ribosome binding allows nascent 
chain insertion in cotranslational translocation 13. In our system, disulfide crosslinking at the 
periplasmic side made channel insertion irreversible.
The disulfide-bridged complex of B. subtilis SecA-OAIns and G. thermodenitrificans SecYE 
was purified and crystallized in the presence of ADP and BeFx (Extended Data Fig. 3), 
conditions that lock SecA into a conformation close to its ATP-bound state and maximize 
SecA's affinity for the channel 9,14. The diffraction of the crystals was improved by the use 
of single-domain antibody fragments (nanobodies), raised against G. thermodenitrificans 
SecYE and selected for binding to periplasmic loops of the SecA-OAIns/SecYE complex, 
and by soaking crystals with a Ta6Br12 metal ion cluster. The structure was determined from 
multi-wavelength anomalous diffraction (MAD) data obtained with a crystal that diffracted 
to a resolution of 3.70 Å along one axis and 4.48 Å along the other two (Fig. 1b; Extended 
Data Fig.4; Extended Data Table 1). An initial experimental electron density map had a 
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resolution of ~5.5Å. This map was improved by density modification and molecular 
replacement using higher resolution structures of SecA, SecYE, and the nanobody, followed 
by cycles of model building and refinement. Inclusion of the model-refined Ta6Br12 clusters 
as the resolved heavy atom substructure for recalculation of MAD phases did not further 
improve the map. Nevertheless, the final map allowed the unambiguous placement of all 
TMs of SecY and SecE and of many other regions. The translocating polypeptide segment 
could be built into the map without model bias (Extended Data Fig. 4c). As expected, the 
nanobody bound to the periplasmic side of SecY, interacting with both the plug and the loop 
between TMs 3 and 4 (Fig. 1b; Extended Data Fig.5a).
The structure of the active channel shows that SecA undergoes relatively small 
conformational changes compared to a Thermotoga maritima complex lacking a 
translocating chain 9 (Extended Data Fig.6). SecA binds to the cytoplasmic loop between 
TMs 8 and 9 and the C-terminal tail of SecY (Extended Data Fig. 5b, c). It probably binds 
only weakly to the loop between TMs 6 and 7, as its tip is disordered. In contrast to the 
ribosome 6-8, SecA also binds to the N-terminal half of SecY, i.e. the loop between TMs 2 
and 3 (Extended Data Fig.5b). Thus, at least in its ATP-bound state, SecA prevents large 
relative movements of the two halves of SecY.
SecY also undergoes relatively small changes, except at the lateral gate (Fig. 2). Compared 
with the idle Methanocaldococcus jannaschii or Thermus thermophilus channels 1,3, only 
TM7 (M.j.) or TM7 and TM8 (T.t.) significantly shift their positions (Fig. 2a; Extended Data 
Figs. 7a). Compared to the SecA-bound T. maritima channel 9, the periplasmic ends of TMs 
3 and 7 move towards each other and TM 7 tilts by 10° relative to the plane of the membrane 
(Fig. 2b), changes that generate a pocket for the signal sequence (see below). In both 
structures, the lateral gate is partially open (compare Figs. 2a and 2b).
In the active G. thermodenitrificans SecY channel, the plug consists of two β-strands and 
therefore differs from the α-helical structures observed in other species 1,4,5,9 (Extended 
Data Fig. 8a). Such variability is consistent with the fact that the amino acid sequence of the 
plug region is least conserved 1, and that plug deletions cause neighboring polypeptide 
regions to form new plug domains 15. Different plug structures can probably be tolerated, as 
long as they fill the extracellular cavity of the channel, so that the closed state of the channel 
is stabilized and small molecules cannot pass through it. However, it is possible that the plug 
has different conformations in the closed and active channels.
Whereas the plug is close to the central constriction in the closed M. jannaschii channel 1, in 
the active G. thermodenitrificans channel it moves to the periplasmic side and towards the 
back of the channel, away from the lateral gate (Fig. 2c). The plug comes close to the TM of 
SecE, consistent with disulfide crosslinking experiments 16,17. In a SecA-SecY structure 
lacking a translocation substrate 9, the plug moves a smaller distance and towards the front 
(Fig. 2d), partially sealing the opened lateral gate (Extended Data Fig. 8b). In an intact 
membrane, this would prevent surrounding lipid molecules from moving through the lateral 
gate into the extracellular cavity. The plug is likely flexible in the active channel, but in our 
crystal structure, it is confined both by the disulfide bond to the translocating chain and by 
the interaction with the nanobody (Extended Data Fig.5a). Indeed, in a 6.5Å resolution 
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structure determined without nanobody, the plug is shifted further towards the back, 
although there are otherwise only small differences (Extended Data Fig. 9a).
The signal sequence of the secretory protein segment forms a helix that is tilted ~45° relative 
to the plane of the membrane (Fig. 3a). The positively charged N-terminus of the signal 
sequence (N-region) is in the same plane as hydrophilic residues of SecY. In an intact 
membrane, the N-region could interact with the negatively charged head groups of the 
phospholipid bilayer. This interaction may retain the N-terminus on the cytoplasmic side of 
the membrane while the C-terminal end of the signal sequence moves through the channel, 
resulting in loop insertion of the translocating polypeptide.
The hydrophobic core of the signal sequence (H-region; residues −17 to −6 of the original 
OmpA sequence; Fig. 1a) sits in a groove outside the lateral gate of SecY and forms a helix 
that runs almost parallel to TM2 (Fig. 3a, b). Some residues make van der Waals contacts 
with hydrophobic amino acids in TM2 (Extended Data Fig. 7c), but most face detergent 
(Fig. 3b), and would be in contact with hydrocarbon chains of phospholipids in an intact 
membrane.
The C-terminal region of the signal sequence (C-region; residues −5 to −1; Fig. 1a) replaces 
the periplasmic end of TM7 in the closed M. jannaschii channel (Extended Data Fig. 7b). 
This segment forms a distorted, amphipathic α-helix that is intercalated between TM7 and 
TM3 into the periplasmic side of the lateral gate (Fig. 3a,c). In our model, the side chains of 
Thr(−5) and Ser(−2) point into the periplasmic cavity previously occupied by the plug in the 
closed channel (Extended Data Fig. 7d). The hydrophobic residues Val(−4) and Ala(−3) face 
detergent/lipid. The lateral gate is thus sealed by the C-region from surrounding lipid 
molecules, which could otherwise pass through a large opening generated by the 
displacement of the plug from the front (Figs. 3c). After signal sequence cleavage, the 
periplasmic parts of TMs 7 and 3 probably move towards each other and seal the lateral gate.
The hydrophilic polypeptide segment following the signal sequence adopts a partially 
extended conformation with a loop in the periplasmic cavity, centered on the cysteine used 
for crosslinking to the plug. The signal sequence cleavage site is located inside the channel 
(Fig. 3c), likely inaccessible to the periplasmically disposed active site of signal 
peptidase 18. Thus, at some point during translocation, the C-region of the signal sequence 
probably must adopt a more extended conformation, a change also suggested by experiments 
with synthetic signal peptides 19,20.
The polypeptide chain inside the channel is perpendicular to the plane of the membrane (Fig. 
3a). The two strands of the hairpin formed by the translocating polypeptide do not interact 
with one another, so that during translocation the C-terminal part of the hairpin could move 
unimpeded through the center of the channel. Our model places residue Gly(+19), or one of 
the neighboring residues (Ala18 or Gly20), of the translocating polypeptide inside the pore 
ring (Fig. 3d). The density around Gly19 is particularly strong, indicating that this segment 
is confined by the surrounding four pore ring residues (Ile78, Ile183, Ile275, Ile404). The 
ring is wider than in the idle M. jannaschii or SecA-bound T. maritima channels (diameters 
8.8Å versus 5.6Å or 6.6Å, respectively). Crystallization may have favored the presence of 
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small amino acids in the pore, minimizing its expansion by the presence of a translocating 
chain. However, even a small increase in pore diameter would allow the passage of amino 
acids with larger side chains. The pore ring residues fit snugly around the translocating 
polypeptide (Fig. 3e), confirming that they form a “gasket” that maintains the permeability 
barrier for ions and other small molecules during translocation 21. Consistent with disulfide 
crosslinking experiments 22, only pore ring residues contact the translocating chain (Fig. 3d). 
Thus, the hourglass-shape of the channel minimizes interactions with the translocation 
substrate, facilitating its movement through the channel.
The pore ring of the idle M. jannaschii channel contains two additional residues (Ile75 and 
Ile170; Fig. 3f). In the active channel, the corresponding residues (Val74, Leu179) are 
displaced (Fig. 3e). The pore “ring” is thus open at the lateral gate between Ile78 in TM2 
and Ile275 in TM7 (Fig. 3e). These features suggest that a translocating polypeptide segment 
continuously encounters the hydrocarbon chains of surrounding lipids; when sufficiently 
hydrophobic, the segment will partition into the lipid phase and become a TM domain of a 
membrane protein 23,24.
Our crystal structure likely reflects the physiological situation of a translocating polypeptide. 
Five of the seven residues of the N-terminal linker are invisible and thus likely flexible, 
allowing unrestricted interaction of the signal sequence with the channel. In addition, most 
polypeptide segments following the signal sequence are in a relaxed conformation, 
unconstrained by fusion to SecA, or the disulfide bridge to the plug. The disulfide bridge 
helps to stabilize the signal sequence in the channel, but it likely does not lead to gross 
distortions, because the plug is mobile and the disulfide bridge is formed spontaneously in 
vivo.
The crystal structure of the active channel leads to a refined model for post-translational 
protein translocation in bacteria (Fig. 4). The SecY channel is initially in the idle state, with 
the plug in the center and the lateral gate closed (Fig. 4a). Binding of SecA primes the 
channel for the arrival of a secretory protein precursor: the lateral gate is partially opened, 
the pore ring widened, and the plug domain moved towards the front (Fig. 4b). Next, the 
secretory protein inserts into the channel as a loop, with the C-terminal section of the 
polypeptide hairpin in the pore proper, surrounded by pore ring residues (Figs. 4c,d). During 
subsequent cycles of ATP hydrolysis, SecA uses a “push-and-slide” mechanism to move the 
C-terminal part of the polypeptide loop through the pore 14. Eventually, the signal sequence 
is cleaved by signal peptidase (Fig. 4e).
During loop insertion, the H-region of the signal sequence moves through the cytoplasmic 
part of the lateral gate and ends up in a hydrophobic groove on the outside, while the 
following hydrophilic segment crosses the lateral opening of the pore ring. A signal 
sequence might move through a partially open gate in an extended conformation, or it could 
move through a widened gate as a preformed helix. The latter possibility is suggested by a 
~10Å-resolution EM structure of a ribosome/nascent chain/channel complex, in which a 
signal sequence helix was seen inside the lateral gate 6, probably prevented from exit by a 
disulfide bridge between a cysteine immediately following the signal sequence and a 
cysteine in the plug. The groove on the outside of the lateral gate site appears to be a general 
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binding site for hydrophobic sequences, as indicated by a 8.5Å resolution structure of a 
complex in which the OmpA signal sequence was replaced by that of DsbA (Extended Data 
Fig. 9b,c), and EM structures of ribosome-channel complexes, in which TMs of nascent 
membrane proteins are located at about the same position 7,25 (Extended Data Fig. 7e). Like 
TMs, signal sequences appear to be recognized mostly by lipid partitioning, consistent with 
their ability to be crosslinked to lipids 26,27, and the correlation between the partitioning of 
synthetic peptides into hydrophobic solvents and their function as signal sequences in vivo 28. Nevertheless, amino acid interactions with TM2 of the channel may contribute to the recognition of signal sequences. This may explain why some amino acids occur more frequently than others in signal sequences, even when they have about the same hydrophobicity: leucine is preferred over isoleucine and valine 29, perhaps because its extended side chain can make tighter van der Waals contacts with residues in TM2. Whereas signal sequences of translocating secretory proteins would tend to stay in the binding pocket until they are cleaved off, the more hydrophobic TMs of membrane proteins could move away once the connecting loop to the polypeptide segment inside the channel pore attains adequate length.
While this paper was under review, a cryo-EM structure was published describing an active 
ribosome-bound mammalian Sec61 channel containing a short secretory polypeptide 
segment 30. The authors conclude that the signal sequence helix replaces TM2 of Sec61α in 
the idle channel, implying that the signal sequence is intercalated into the lateral gate and 
raising the possibility that the conformational changes differ greatly from those in our 
system. However, a superposition of the two active channels based on secondary structure 
matching shows that they are actually very similar, with only moderate differences at the 
periplasmic/luminal ends of some TMs (Extended Data Fig. 7f). Importantly, in both cases 
the signal sequence helix docks to the same site outside the lateral gate and runs parallel to 
TM2 (Extended Data Fig. 7f). Thus, regardless of the organism and mode of translocation, 
lipid partitioning appears to be the major mechanism by which signal sequences are 
recognized.
METHODS
Protein translocation and disulfide crosslinking assays
To test in vivo OmpA-GFP translocation by E. coli SecA and E. coli SecY complex (three-
component system), E. coli strain EP52 or EP62 (Δrmf ΔompT secY-CBP) 12 was 
transformed with pACYC-SecYEG expressing E. coli SecYEG complex with SecY 
containing a unique Cys at position at 68 (ref. 21). The cells also expressed OmpA-GFP from 
pBAD-OmpA-GFP under an arabinose-inducible promoter 12. In all constructs, including 
those used in the two-component system, position −1 of the signal sequence was mutated to 
Tyr to prevent signal peptide cleavage 31. The cells were grown at 37°C to log phase in LB 
medium supplemented with 100 μg/mL ampicillin and 40 μg/mL chloramphenicol. OmpA-
GFP expression was induced by addition of 0.15% L-arabinose for 1 hr. Where indicated, 
0.3 mM copper(II) 1,10-phenanthroline (CuPh3) was added to the bacterial culture for 15 
min at room temperature. The culture was treated with 10 mM N-ethyl maleimide (NEM) 
for 30 min on ice to block free cysteines. The cells were lysed in SDS sample buffer. 
Samples (equivalent amounts based on OD600nm of E. coli cultures) were subjected to non-
reducing SDS-PAGE and analyzed by western blotting with anti-SecY- or GFP-antibodies. 
Where indicated, the samples were treated with 2% β-mercaptoethanol (β-ME) at 50°C for 
20 min prior to SDS-PAGE. To test the translocation of E. coli SecA-OAIns fusion with E. 
coli SecY complex (two-component system), EP52 cells were transformed with pACYC-
SecYEG and pBAD-EcSecA-OAIns. The cells were grown to log phage in LB medium 
supplemented with 100 μg/mL ampicillin and 40 μg/mL chloramphenicol, and SecA-OAIns 
expression was induced by addition of 0.1% L-arabinose for 4 hrs at room temperature or 30 
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min at 37°C. Disulfide crosslinking and non-reducing SDS-PAGE analysis were performed 
as described above.
Translocation by B. subtilis SecA and G. thermodenitrificans SecY complex was tested 
similarly. In the case of the three-component system, E. coli strain EP51 (Δrmf ΔompT) 21 
was transformed with pTet-G. thermodenitrificans SecEHis8/YHis6, which expresses 
bicistronic G. thermodenitrificans SecE and SecY genes (SecY contains a Cys at position 
60) under a tetracycline-inducible promoter 21. The cells were also transformed with pBAD-
OmpA-GFP/B. subtilis SecA, a modified version of pBAD-OmpA, which contains an 
additional ribosome binding site and the B. subtilis SecA gene (for bicitronic expression) 
following OmpA-GFP. In the case of the two-component system, EP51 cells were 
transformed with pTet-G. thermodenitrificans SecEHis8/YHis6 and pBAD-B. subtilis SecA-
OAIns. The cells were grown to log phase at 37°C, and the expression of G. 
thermodenitrificans SecYE was induced by addition of 200 ng/mL anhydrotetracycline for 
1.5–2 hrs at 37°C. Then, the expression of OmpA-GFP/BsSecA or BsSecA-OAIns was 
induced by addition of 0.2% L-arabinose for 1–3 hrs. The cells were collected and subjected 
to SDS-PAGE followed by western blotting as described above. G. thermodenitrificans SecY 
was detected using anti-His antibodies.
Nanobody library generation
Purified G. thermodenitrificans SecYE in DDM-containing buffer was injected into an 
alpaca to elicit an immune response. A male alpaca (V. pacos) was purchased locally, 
maintained in pasture, and immunized following a protocol authorized by the Tufts 
University Cummings Veterinary School Institutional Animal Care and Use Committee. 
Following five rounds of immunization, total RNA was isolated from ~106 fresh peripheral 
blood lymphocytes, using the RNeasy Plus Mini Kit (Qiagen), following the manufacturer's 
instructions. Total RNA was used to synthesize a cDNA library using SuperScript III reverse 
transcriptase (ThermoFisher Scientific, Waltham MA) with a combination of random 
hexamers, oligo(dT), and gene-specific primers. The variable fragments of heavy chain 
antibodies (VHHs) segments were further amplified from this cDNA library using primers 
specific to the VHH region 32. PCR products were pooled, digested with NotI-HF and AscI 
(NEB, Ipswich, MA), gel purified, ligated into a M13 phagemid vector (pJSC), and 
transformed via electroporation into TG1 E. coli (Agilent, Santa Clara, CA). Library 
complexity was assessed by serial dilution and plating on 2YT agar plates supplemented 
with 2% glucose and 10 μg/ml ampicillin.
Selection of nanobodies by phage display
Purified SecYE and SecA-OAIns/SecYE proteins were biotinylated via coupling to primary 
amines with a fivefold molar excess of Chromalink NHS biotin reagent (Solulink, San 
Diego, CA) for 90 min. Excess biotin reagent was removed using a ZeBa desalting column 
(ThermoFisher Scientific, Waltham MA). Twenty μg of each protein were mixed with 100 μl 
MyOne Streptavidin T1 Dynabeads (ThermoFisher Scientific) blocked with 2% BSA. The 
beads were incubated with 200 ul of 1013 pfu/ml phage for 1 hr at room temperature. Non-
binding phage were washed away and bound phage was eluted first by incubating with 1ml 
of saturated ER2738 culture, followed by 200mM pH2.2 glycine. The elutions were 
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neutralized, pooled, and plated onto 2YT agar plates supplemented with 2% glucose, 5 
μg/ml tetracycline, and 10 μg/ml ampicillin. A second round panning was performed with 2 
μg of each protein and 40 μl MyOne Streptavidin T1 Dynabeads. All procedures were 
conducted in 20 mM Tris-HCl pH7.5, 150 mM NaCl, 10% glycerol, 0.02% DDM for 
SecYE, and with 20mM HEPES-KOH pH7.0, 150 mM NaCl, 10% glycerol, 0.02% DDM, 
5mM MgCl2, 0.1mM ADP/BeFx for SecA-OAIns/SecYE. For each protein, 95 clones were 
sequenced, and sequences that appeared more than 5 times were selected for subsequent 
validation.
Nanobody screening
Thirteen distinct families of nanobodies directed against G. thermodenitrificans SecYE were 
identified by DNA sequencing. Twenty-two nanobody clones were sub-cloned into the 
pHEN6 vector 33, which adds an N-terminal pelB sequence and C-terminal sortase and His6 
tags (LPETGG-His6). The proteins were expressed in 5ml E. coli cultures. After Ni-resin 
purification, the nanobodies were labeled with Alexa 555 (Invitrogen) by sortase reaction 34. 
The labeled nanobodies (1 μM concentration) were mixed with G. thermodenitrificans 
SecA-OAIns/SecYE complex or with SecYE alone at a molar ratio of 2:1. Nanobody 
binding was monitored by a shift of the peak in size-exclusion chromatography coupled with 
a fluorescence detector (Shimadzu). All 22 nanobodies bound to SecYE, but only nanobody 
AYC08 had a high affinity for SecA-OAIns/SecYE. The binding of AYC08 to free SecYE 
was weaker than to SecA-OAIns/SecYE, indicating that AYC08 interacts with the 
periplasmic side of SecY and that the binding epitope is only fully exposed in the active 
channel.
Protein Expression and Purification
E. coli strain EP51 was transformed with pTet- G. thermodenitrificans SecEHis8/Y and 
pBAD-B. subtilis SecA-OAIns49(L7). Residues 202-213 in the loop between TMs 5 and 6 
of SecY were replaced by the sequence TFGGLN. Cells were grown in LB medium 
supplemented with 100 μg/mL ampicillin, 40 μg/mL chloramphenicol, and 0.5% glycerol at 
37°C until OD 600nm reached 0.6–0.7. The expression of the G. thermodenitrificans SecYE 
was induced by addition of 200 ng/mL anhydrotetracycline, and cells were incubated for 1.5 
hrs at 37°C and additional 1 h at 22°C. Then 0.15% L-arabinose was added to the culture to 
express B. subtilis SecA-OAIns overnight at 16°C. Cells were harvested by centrifugation 
and stored at −80°C until use.
The cells were suspended in buffer A (20 mM Tris-HCl pH7.5, 150 mM NaCl, 1 mM 
phenylmethanesulfonyl fluoride; IPTG) and lysed in a microfluidizer (Microfluidics). The 
membranes were pelleted by ultracentrifugation, washed once with buffer B (20 mM Tris-
HCl pH7.5, 300 mM NaCl), and solubilized with 1% n-dodecyl β-D-maltoside (DDM; 
Anatrace) in buffer C (20 mM Tris-HCl pH7.5, 150 mM NaCl, 10% glycerol). After 1 hr 
incubation at 4 °C, the solution was clarified by ultracentrifugation. The supernatant was 
loaded onto a 5 ml POROS-MC20 column (Applied Biosystems) pre-charged with CoCl2. 
After washing with 15 ml of buffer D (as buffer C, but with 0.02% DDM) containing 10 mM 
imidazole and 5 ml of buffer D containing 15 mM imidazole, the protein was eluted with 5.5 
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ml of buffer D containing 250mM imidazole. Immediately after elution, 1 mM ADP/BeFx, 5 
mM MgCl2, and 0.1 mg/ml E.coli polar lipids (25 mg/ml stock dissolved in 1% DDM) were 
added. To cleave the GFP-strep tag, 3C protease was added at a ratio of 1:30 (w:w) and 
mixture was incubated overnight at 4 °C. The sample was diluted 1:1 (v:v) with buffer E (20 
mM Tris-HCl pH7.5, 10% glycerol, 0.02% DDM, 5 mM MgCl2) and loaded onto a Mono Q 
10/100 column (GE Healthcare). The protein was eluted with a gradient of 15%-35% buffer 
F (20 mM Tris-HCl pH7.5, 1 M NaCl, 10% glycerol, 0.02% DDM, 5 mM MgCl2). The peak 
fractions were collected, and 0.1 mg/ml E .coli polar lipids and 1 mM ADP/BeFx were 
added. The protein was concentrated with an Amicon filter (100 kD MWCO, EMD 
Millipore) and loaded onto a Superdex 200 10/300 column (GE Healthcare) in buffer G (20 
mM HEPES-KOH pH7.0, 100 mM NaCl, 10% glycerol, 0.02% DDM, 5 mM MgCl2, 1 mM 
ADP/BeFx). The peak fractions were concentrated to ~12 mg/ml, aliquoted, and flash-frozen 
in liquid nitrogen. The protein was stored at −80 °C and thawed right before crystallization.
The plasmid coding for nanobody AYC08 was transformed into WK6 cells. The cells were 
grown in 2×YT medium at 37 °C and protein expression was induced with 0.5 mM IPTG at 
OD600 0.6. The incubation was continued overnight at 30 °C. About 5 grams of cells were 
obtained from 1 L of culture. After suspension in 15 ml of TES buffer (200 mM Tris-HCl 
pH8.0, 500 μM EDTA, 500 mM sucrose), the sample was diluted 1:3 (v:v) in ice-cold water 
for 3 hrs to induce cell lysis. After centrifugation, the supernatant was mixed with 5 ml of 
Ni-NTA resin (Qiagen) and incubated at 4 °C for 1 hr. The protein was eluted with 250mM 
imidazole. The protein was further purified by gel filtration on a Superdex 200 10/300 
column in 20 mM HEPES-KOH pH7.0, 100 mM NaCl, 10% glycerol, 5 mM MgCl2). The 
purified nanobody was concentrated to 30 mg/ml.
Crystallization
Initial crystals were obtained with a complex of G. thermodenitrificans SecYE and either B. 
subtilis SecA-OAIns and or B. subtilis SecA-DsbAIns (the latter contains the signal 
sequence of DsbA instead of that of OmpA). Only small crystals were obtained and 
diffracted to a maximum resolution of 6.5 Å at the Synchrotron X-ray source. A variety of 
approaches were tested to improve the crystals, such as inserting different hydrophilic 
proteins into each of the periplasmic loops of SecY (T4 lysozyme 35, cytochrome b562 36, 
P1/P4 domain of SecD/F 37, ROP helical bundle 38), truncating SecY loops, using various 
detergents, co-expressing SecG, and employing Fab-fragments of monoclonal antibodies 
generated against SecY. However, crystals with improved diffraction were only obtained 
when the complex was co-crystallized with nanobody AYC08.
The complex of G. thermodenitrificans SecYE and B. subtilis SecA-OAIns was mixed with 
nanobody AYC08 at a molar ratio of 1:1.2 with addition of 1 mg/ml lipids (42 mg/ml 1,2-
dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG) plus 1,2-dipalmitoylsn-glycero-3-
phosphoethanolamine (DPPE) (3:1) suspension in 0.5% DDM) 39. The mixture was 
incubated at 4 °C overnight and clarified by ultracentrifugation before setting up 
crystallization trays. The initial crystal screening yielded several crystal forms. Three of 
them were readily reproducible, but all diffracted to a maximum of ~6 Å resolution. Heavy 
atom compounds were screened for crystal soaking and the Ta6Br12 cluster improved the 
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resolution limit of one crystal form. The best crystals were obtained with the hanging drop 
method, mixing 0.5 μl of the protein solution and 0.5 μl of well solution (21-24% 
polyethylene glycol (PEG) 1500, 100mM Tris-HCl pH8.5, 50-100 mM MgAc2, 2% 2-
methyl-2,4-pentandiol; MPD) and using 24 well VDX plates with 500 μl well solution. The 
crystals were grown at 22°C over a week. The Ta6Br12 powder (Jena Bioscience) was 
suspended in buffer at a concentration of 20 mM and added to the crystallization drops at a 
final concentration of ~2 mM. After overnight incubation, the crystals were flash-frozen in 
liquid nitrogen
X-ray data collection and structure determination
Hundreds of crystals were screened at NE-CAT and GM/CA-CAT of the Advanced Photon 
Source (APS, Argonne National Laboratory). The diffraction of the crystals decayed rapidly 
and was weak, caused by strong heavy atom absorption. However, a complete set of three-
wavelength MAD data from a single crystal could be collected at GM/CA-CAT. The data 
were processed with the XDS package40 and analyzed by the program Aimless41. The 
crystal belongs to the P6122 space group. The diffraction was anisotropic. Along axis c*, the 
diffraction went beyond 3.70 Å (I/sigma=2.0), whereas along the axes a* and b*, the 
diffraction was limited to 4.48 Å (I/sigma=1.5). The data were initially processed to 3.9 Å. 
Anisotropy correction was applied in the different programs used in the following 
calculations. Molecular replacement was used to locate SecA, SecYE, and the nanobody, 
employing as search models B. subtilis SecA (PDB ID: 1TF5), T. maritima SecYE (PDB ID:
3DIN), and an anti-DHFR nanobody (PDB ID: 4EIG), respectively. The crystal contained 
one complex per asymmetric unit with a solvent content of 69%. Heavy atom sites were 
identified with the molecular replacement results by MR-SAD in Phaser42 and refined 
without molecular replacement models in Sharp (Global Phasing Limited). The experimental 
map based on the positions of the heavy metal ion clusters contained useful phase 
information to 5.5 Å (judged by phasing power of 1). The overall figure of merit was 0.44 
(acentric) and 0.42 (centric). The phases were extended to 3.9 Å through density 
modification, using the programs Resolve43 and CNS44. After density modification, most of 
the α-helices were well resolved and some of the large side chains were visible in B-factor 
sharpened maps. To improve the density map, model phases were combined with 
experimental phases. Models for SecA and the nanobody molecules were placed first and 
modified according to the density map. Model phases were then combined with 
experimental phases to improve the density map. The SecY and SecE molecules were then 
built with the guidance of B-factor sharpened maps and the crystal structures of T. 
thermophilus 4 and T. maritima SecYE9. A density map for tracing the translocating peptide 
was generated by combining phase information from MAD phasing, and models of SecA, 
nanobody, and SecYE (Extended Data Fig. 4c). The signal sequence was initially modeled 
as an ideal poly-Ala helix and placed into the density map. The registry of the signal 
sequence helix was then determined from the density for two aromatic residues (Phe(−7) and 
Tyr(−1)). The following 23 amino acids of the translocating peptide were traced in a B-
factor sharpened density map. The registry of this segment was determined on the basis of 
density for an aromatic residue (Phe3), several negatively charged residues (Glu4, Asp5, 
Glu10, and Glu12) surrounding the positively charged Ta6Br12 cluster, and the cysteine 
engaged in the disulfide bond (Cys7). Our model places Gly19 inside the pore ring, but it is 
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possible that the registry is off by one residue (Ala18 or Gly20 would be in the pore), an 
ambiguity that does not alter the interpretation of the model. Annealing to a temperature of 
2,500 K was applied to the model at an early stage of refinement with the program Phenix45. 
The individual XYZ and group B factors were refined by using both the Phenix and 
Refmac546 programs. Secondary structure was tightly constrained during refinement. The 
SAD likelihood function implemented in Refmac5 was used to refine the heavy atom 
clusters together with the protein model. The model was improved by molecular 
replacement and multiple cycles of model building and refinement. Manual adjustments 
were made in COOT47 and refinement was performed in reciprocal space. At a late stage of 
refinement, the diffraction data were extended to 3.7 Å, which helped to resolve some 
regions in the density map, e.g. of the translocating peptide. We also tested the data with 
ellipsoidal truncation processed by the Anisotropy server (http://services.mbi.ucla.edu/
anisoscale/). The truncated data produced better density maps, which were used for 
refinement as well. The final model was refined to an Rwork of 30.6% and an Rfree of 32.5% 
and showed good geometry (Extended Data Table 1). An attempt was made to include the 
model-refined Ta6Br12 clusters as the resolved heavy atom substructure for recalculation of 
SAD and MAD experimental phases. However, this did not result in improvement of the 
map, in part because individual metal atoms of the clusters could not be accurately 
positioned, as observed in other cases of similar resolution 48. While the centers of the 
clusters are well defined, the individual metal atom positions in our model should be 
considered to be very approximate. To ensure that the R-factor is not dominated by the 
heavy metal ion clusters, we tested its sensitivity to changes in the protein model. Rfree 
increased by 0.013-0.017 upon deletion of any of the TMs of SecY or of the signal sequence 
helix. A similar increase was observed when the same analysis was performed for three 
different membrane proteins of similar size (2ZD9, 4CZB, 4CDI; 1,078-1,655 amino acids), 
the structure of which was determined in the absence of heavy metal ion clusters at similar 
resolution (3.5-4Å), solvent content (0.63-0.85), and R-factor (0.3-0.34). Model validation 
was performed by using PHENIX. The following regions could not be traced: residues 1-15, 
244-247, 262-264, 271-272, 620-626, and 635-712 of SecA, residues 1-12, 145-146, 
200-213, 244-260, and 291-308, 390-391, and 396-398 of SecY, residues 1-3, 22-23, 58-60 
of SecE, residues 30-31, 42, and 100 of the nanobody, and the first 5 residues of the linker 
preceding the signal sequence. In addition, some amino acid side chains were not well 
resolved, so they were modeled as Ala. Some density close to metal ion cluster sites 15 to 18 
remains unexplained. Figures showing the structures were generated with Chimera49. All the 
X-ray crystallographic software was maintained by SBGrid50.
Li et al. Page 11
Nature. Author manuscript; available in PMC 2016 September 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Extended Data
Extended Data Figure 1. Generation of translocation intermediates with a three-component 
system
a, Strategy to generate SecA-dependent translocation intermediates in E. coli cells. The 
intermediates are assembled from E. coli SecA, E. coli SecY complex, and substrate that 
contains an N-terminal OmpA signal sequence and C-terminal superfolder GFP51 (sfGFP). 
After loop insertion into the SecY channel, translocation of the C-terminus is stalled by the 
folded sfGFP. Insertion is monitored by disulfide bond formation between a pair of cysteines 
introduced into the substrate and the plug of SecY (yellow stars). b, Scheme showing the 
simplified system, in which a secretory protein segment is fused into the two-helix finger of 
SecA. c, Sequence of the substrate used in a. The −1 position of the original signal sequence 
was changed to Tyr to prevent signal sequence cleavage. The position of the cysteine and the 
length of the translocated segment were varied (here shown for Cys at position +3 and 58 
amino acids length). d, Variation of the Cys position with a translocationg segment of 58 
residues. Where indicated, disulfide crosslinks to SecY with a Cys at position 68 (OmpA-
GFPxSecY) were induced by the oxidant copper phenanthroline (CuPh) prior to harvesting 
the cells. The samples were analyzed by non-reducing SDS-PAGE, followed by western 
blotting (WB) with anti-SecY and anti-GFP antibodies. e, As in d, but in the absence of 
oxidant, with Cys at different positions and variation of the length of the translocated 
segment. Asterisks indicate nonspecific bands. f, As in e, but with E. coli cells expressing B. 
subtilis (B.s.) SecA and G. thermodenitrificans (G.t.) SecYE. The substrate contained a Cys 
at position +7, and SecY a Cys at position 60. The red arrows indicate spontaneously 
generated disulfide crosslinks (GFP sometimes does not unfold in SDS, resulting in two 
bands). The OmpA-GFP constructs contained a C-terminal Strep-tag that was detected by 
StrepTactin conjugated with horse radish peroxidase (HRP).
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Extended Data Figure 2. Generation of translocation complexes with SecA-substrate fusion 
constructs
a, Translocation complexes were generated as indicated in the scheme in Extended Data Fig. 
1b. An E. coli SecA-substrate fusion (SecA-OAIns74 (L12)) was overexpressed together 
with E. coli SecY complex in E. coli cells. SecA-OAIns74 (L12) contains 74 amino acids 
inserted into the two-helix finger of SecA, including a linker of 12 residues, and a GFP tag 
following SecA. Translocation of the substrate segment was monitored by spontaneous 
disulfide crosslinking between a cysteine at position +7 (with respect to the original signal 
peptidase cleavage site) and a cysteine at position 68 in the plug of SecY. Where indicated, 
β-mercaptoethanol (β-ME) was added to reduce the disulfide bond. The samples were 
analyzed by non-reducing SDS-PAGE and western blotting with anti-SecY antibodies. The 
overexpression of SecA-OAIns was monitored by the fluorescence of GFP (data not shown) 
and staining with Coomassie blue (CBB, lower panel). b, As in a, but with E. coli SecA-
OAIns constructs containing from 6 to 12 residues in the linker (L6-L12) or mutations (3Q) 
in the H-region of the signal sequence. Expression of SecA-OAIns was verified by the 
strong green fluorescence of cell lysates, caused by GFP fused to the C-terminus of SecA 
(not shown). The lower panel shows the sequences of the SecA-inserted segments. c, As in 
a, but with B. subtilis SecA-OAIns74 (L12) and G. thermodenitrificans SecYE. SecY and 
SecA were detected by western blotting with anti-His antibodies and Ponceau staining, 
respectively. d, As in c, but with B. subtilis SecA-OAIns containing different inserted 
segments. SecA-OAIns was expressed for under different conditions, as indicated. 
Expression of SecA-OAIns was verified by green fluorescence of GFP fused to the C-
terminus of SecA (not shown) and Ponceau staining (second panel). The sequences of the 
constructs are shown in the lowest panel. e, As in d, but with different constructs, the 
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sequences of which are shown in the lower panel. Where indicated, copper phenanthroline 
(CuPh) was added to the cells to induce disulfide bridge formation. SecA-OAIns49(L7) was 
used for crystallization. f, As in e, but with a Cys at position −1 (the last residue of the 
OmpA signal sequence) instead of position +7. Note that in this case disulfide formation 
does not occur spontaneously.
Extended Data Figure 3. Purification of an active translocation complex
a, Scheme of the purification protocol. b, Elution of the G. thermodenitrificans SecYE – B. 
subtilis SecA-OAIns complex from a Superdex200 column during the last chromatography 
step. c, Non-reducing SDS-PAGE analysis of samples taken during the purification 
procedure and of fractions indicated with red numbers in b. Lane 1, molecular weight 
markers. Lane 2, sample analyzed after IMAC. Lane 3, sample after cleavage of the GFP 
tag. Lane 4, sample after anion exchange chromatography (MonoQ).
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Extended Data Figure 4. Electron density map and refined model
a, Stereo view of the unsharpened density map (2FO-FC; 1σ) of the entire complex. Heavy 
metal ion clusters are shown in yellow. b, As in a, but with the density map derived from 
MAD phasing after density modification. c, SigmaA-weighted phase-combined 2FO-FC 
density maps of the translocating peptide region. The left panel shows an omit map 
calculated without a model for the translocating peptide. The right panel shows a map 
calculated with the model. Phe (−7) is one of the residues used to determine the registry of 
the helix. d, A side view of the density for TMs 3 and 4. e, Density showing the disulfide 
crosslink between the plug and translocating chain. f, Top view of Gly19 of the translocating 
chain surrounded by pore residues.
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Extended Data Figure 5. Interactions of the nanobody and SecA with SecY
a, The nanobody binds to the plug and to the loop between TMs 3 and 4 (L3/4). b, The 
polypeptide crosslinking domain (PPXD; in yellow) of SecA interacts with the loop between 
TMs 8 and 9 of SecY (L8/9; in red), and the long helix of the helical scaffold domain (HSD; 
in blue) with the loop between TMs 2 and 3 (L2/3; in red). The loop between TMs 6 and 7 
of SecY (L6/7; in red) does not seem to make strong contact with SecA. c, Two helices of 
the HSD interact with the C-terminal tail of SecY (C-tail; in red).
Extended Data Figure 6. Comparison of the conformations of SecA in the active G. 
thermodenitrificans and inactive T. maritima complexes
The domains of SecA in the G. thermodenitrificans complex are labeled with different colors 
(nucleotide binding domain 1 (NBD1), blue; nucleotide binding domain 2 (NBD2), cyan; 
helical scaffold domain (HSD), brown; helical wing domain (HWD), grey; polypeptide 
crosslinking domain (PPXD), yellow). SecA in the T. maritima complex is shown in pink. 
The left panel shows a top view (the channel would be underneath), and the right panel a 
side view with the two-helix finger (part of HSD) indicated.
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Extended Data Figure 7. Localization of signal sequences in the G. thermodenitrificans SecY and 
mammalian Sec61 channels and of a TM domain in the mammalian Sec61 channel
a, In the active channel (salmon), the signal sequence displaces TM7 and TM8 in the idle T. 
thermophilus channel (cyan). b, As in a, but comparison with the idle M. jannaschii channel 
(tan). The C-region of the signal sequence takes the position of TM7. c, Side view of the 
interactions of the H-region of the signal sequence with TM2 of G. thermodenitrificans 
SecY. Interacting amino acids are indicated. d, Stereo view showing the intercalation of the 
C-region into the periplasmic side of the lateral gate. Residues of the amphipathic helix are 
indicated. e, The active G. thermodenitrificans channel (in salmon) was aligned with a 
mammalian channel (in grey) containing a nascent membrane protein (PDB ID: 4CG6) 
using secondary structure matching 47. The signal sequence in the bacterial channel is shown 
in green, and the TM segment of the nascent membrane protein in yellow. f, As in e, but 
comparison of the active G. thermodenitrificans channel with a mammalian Sec61 channel 
(light blue) containing a secretory protein fragment (PDB ID 3JC2). The signal sequences 
are shown in green and yellow, respectively.
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Extended Data Figure 8. The plug domains in SecY channels
a, The plugs in channels of different organisms have different structures. Shown are side 
views with the plugs in yellow and pore residues as red spheres. PDB IDs are given below 
the names of the organisms. For the G. thermodenitrificans channel, the translocating 
peptide segment was omitted. b, In the inactive T. maritima SecY channel, the plug (in 
yellow) is at the front of the channel, partially sealing the periplasmic side of the lateral gate. 
Shown is a side view in a surface representation, with hydrophilic and hydrophobic residues 
in blue and orange, respectively.
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Extended Data Figure 9. Structures of the active G. thermodenitrificans complex determined 
without nanobody or with a different signal sequence
a, Stereo view of density maps at 6.5Å resolution for the active complex in the absence of 
nanobody. Shown is a 2FO-FC density map at 1σ (blue mesh) and a difference map (FO-FC) 
at 3σ (green mesh), both calculated by molecular replacement with a model lacking the plug. 
Strong positive density is seen close to SecE, likely corresponding to parts of the plug. The 
arrow indicates the movement of the plug from the position in the structure with nanobody 
to the density seen in the structure without nanobody. b, Stereo views of density maps at 
~8.5 Å resolution for the active G. thermodenitrificans complex in which the OmpA signal 
sequence was replaced by that of DsbA. Shown is a side view of the 2FO-FC density map at 
1σ (blue mesh) and a difference map (Fo-Fc) at 3σ (green mesh), both calculated by 
molecular replacement with a model lacking the signal sequence. Note that the model for the 
OmpA signal sequence fits well into the density corresponding to the DsbA signal sequence. 
c, As in b, but top view and not in stereo.
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Figure 1. Architecture of the active SecY channel
a, A secretory protein segment was inserted into the two-helix finger of the SecA ATPase 
(SecA-OAIns). The segment contains a linker (grey), the signal sequence of OmpA, 
consisting of the N-, H-, and C-regions (in red, black, and purple letters, respectively), and a 
region (in light green) that includes a unique cysteine (yellow star). Residues in the signal 
sequence are numbered backwards from the cleavage site. The fused segment inserts into the 
SecY channel in vivo and spontaneously forms a disulfide bridge with a cysteine in the plug. 
This complex was used for structure determination. b, Ribbon diagram of the complex, 
viewed from the side. The numbers refer to TMs of SecY. The lines indicate the membrane 
boundaries. A nanobody was used for crystallization.
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Figure 2. Conformational changes of the SecY channel
a, Comparison of the lateral gate of the active G. thermodenitrificans channel (salmon, 
except for TM7 in cyan) with the closed SecY channel of M. jannaschii (in tan). The largest 
changes are indicated by arrows. The translocating peptide segment is omitted for clarity. b, 
As in a, but a comparison with that of the SecA-bound T. maritima channel lacking a 
translocating polypeptide (pink). c, Comparison of the plugs (orange for idle M. jannaschii 
channel and yellow for the active G. thermodenitrificans channel). Pore residues are shown 
as red spheres. d, As in c, but comparison with the inactive T. maritima channel (plug in 
magenta).
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Figure 3. The polypeptide in the channel
a, Cut-away side view of the translocating polypeptide. The N-, H-, and C-regions of the 
signal sequence are indicated. b, View perpendicular to the axis of the signal sequence helix. 
c, Side view showing the translocating polypeptide together with a surface representation of 
the channel, with hydrophilic and hydrophobic residues in blue and orange, respectively. d, 
Side view of a cut through a surface representation model, with the main chain of the 
translocating chain shown as blue sticks. The residues located in the pore ring (red) are 
indicated. The plug is in orange. e, Top view of a slab, showing pore residues and Gly19 of 
the translocating chain as stick and balls with a mesh surface representation. Pore residues 
displaced in the active channel are in yellow. f, As in e, but with the closed M. jannaschii 
channel. I75 and I170 correspond to V74 and L179 in G. thermodenitrificans, respectively.
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Figure 4. Scheme of SecA-mediated protein translocation
Stage ‘a’ corresponds to the closed channel 1-3, stage ‘b” to the structure of the inactive 
SecA-SecY complex 9, stage ‘c’ represents an intermediate to stage ‘d’, which corresponds 
to the structure of the active channel. Stage ‘e’ is attained after signal sequence cleavage. 
The translocating polypeptide is shown in green and the signal sequence as a green cylinder. 
The lateral gate of the channel is shown as a broken line on the left. The clamp of SecA is 
indicated.
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